In this study, we have demonstrated that this epigenetic modulator contributes to the potent suppressive activity of Th1-like iTregs by negatively regulating Sirt1. Increasing our understanding of iTreg differentiation and plasticity will improve Treg-specific therapeutic options for patients with autoimmune disorders, including patients with AA. The gene discussed is SIRT1; the disease is autoimmune disease.